GR862059B - Method for preparing peptidic derivatives of a lactonic or cycloamidic structure - Google Patents

Method for preparing peptidic derivatives of a lactonic or cycloamidic structure

Info

Publication number
GR862059B
GR862059B GR862059A GR860102059A GR862059B GR 862059 B GR862059 B GR 862059B GR 862059 A GR862059 A GR 862059A GR 860102059 A GR860102059 A GR 860102059A GR 862059 B GR862059 B GR 862059B
Authority
GR
Greece
Prior art keywords
cycloamidic
lactonic
peptidic derivatives
preparing
preparing peptidic
Prior art date
Application number
GR862059A
Other languages
English (en)
Inventor
Vincent Michel
Remond Georges
Lepagnol Jean
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of GR862059B publication Critical patent/GR862059B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR862059A 1985-08-05 1986-08-04 Method for preparing peptidic derivatives of a lactonic or cycloamidic structure GR862059B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511936A FR2585709B1 (fr) 1985-08-05 1985-08-05 Nouveaux derives peptidiques a structure lactonique ou cycloamidique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
GR862059B true GR862059B (en) 1986-12-24

Family

ID=9321967

Family Applications (1)

Application Number Title Priority Date Filing Date
GR862059A GR862059B (en) 1985-08-05 1986-08-04 Method for preparing peptidic derivatives of a lactonic or cycloamidic structure

Country Status (15)

Country Link
US (1) US4725581A (el)
EP (1) EP0217688B1 (el)
JP (2) JPS6233198A (el)
AT (1) ATE56976T1 (el)
AU (1) AU581599B2 (el)
CA (1) CA1276397C (el)
DE (1) DE3674525D1 (el)
DK (1) DK364786A (el)
ES (1) ES2000128A6 (el)
FR (1) FR2585709B1 (el)
GR (1) GR862059B (el)
IE (1) IE58541B1 (el)
NZ (1) NZ217079A (el)
PT (1) PT83145B (el)
ZA (1) ZA865826B (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0696575B2 (ja) * 1987-09-17 1994-11-30 三菱化成株式会社 ４−アミノピリジン誘導体及びその酸付加塩
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
FR2649110B1 (fr) * 1989-06-29 1994-10-21 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2663336B1 (fr) * 1990-06-18 1992-09-04 Adir Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5504071A (en) * 1990-10-03 1996-04-02 Polifarma S.P.A. Compounds with a sequence of three radicals, the central one being α-a
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
AU1757597A (en) * 1996-02-05 1997-08-22 Eli Lilly And Company Method of treating beta-amyloid peptide associated conditions using trh
DE19616509A1 (de) * 1996-04-25 1998-01-15 Asta Medica Ag Neue spezifische Immunophilin-Liganden als Antiasthmatika, Immunsuppressiva
JP2005519098A (ja) * 2002-03-01 2005-06-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 変形性関節症の治療方法
US7628342B2 (en) 2004-05-11 2009-12-08 Daiwa Can Company Liquefied gas dispensing nozzle and liquefied gas dispensing apparatus
JP2009524680A (ja) 2006-01-26 2009-07-02 ザ ユニバーシティ オブ ロチェスター 血液脳関門におけるアミロイドβペプチド／ＲＡＧＥ相互作用の阻害

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4260601A (en) * 1979-10-23 1981-04-07 Nyegaard & Co. A/S Chemical compounds
US4293481A (en) * 1980-07-24 1981-10-06 E. R. Squibb & Sons, Inc. Tripeptide inhibitors of angiotensin-converting enzyme
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
EP0217688A1 (fr) 1987-04-08
FR2585709A1 (fr) 1987-02-06
IE58541B1 (en) 1993-10-06
DK364786D0 (da) 1986-07-31
ATE56976T1 (de) 1990-10-15
US4725581A (en) 1988-02-16
AU581599B2 (en) 1989-02-23
PT83145A (fr) 1986-09-01
EP0217688B1 (fr) 1990-09-26
JPH0229680B2 (el) 1990-07-02
DE3674525D1 (de) 1990-10-31
NZ217079A (en) 1988-05-30
JPS6233198A (ja) 1987-02-13
IE862085L (en) 1987-02-05
CA1276397C (fr) 1990-11-13
JPH0259160B2 (el) 1990-12-11
JPH01230597A (ja) 1989-09-14
AU6081286A (en) 1987-02-12
ES2000128A6 (es) 1987-12-16
ZA865826B (en) 1987-04-29
FR2585709B1 (fr) 1987-10-02
PT83145B (pt) 1989-03-30
DK364786A (da) 1987-02-06

Similar Documents

Publication Publication Date Title
IL83925A0 (en) Compositions for treatment of skin disorders
NO173726C (no) Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin
US5443960B1 (en) Method for the diagnosis of blood coagulation disorders
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
AU6747887A (en) Treatment of skin disorders
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
PT84786A (en) Process for the preparation of pharmaceutical formulations of acid labile substances for oral use
EP0278776A3 (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
GR862059B (en) Method for preparing peptidic derivatives of a lactonic or cycloamidic structure
GB8718708D0 (en) Apparatus for treatment of spinal disorders
GB8716925D0 (en) Apparatus for treatment of spinal disorders
NO883612L (no) Fremgangsmaate for fremstilling av nye terapeutisk aktive estere av 9-(2-hydroksyetoksymetyl)guanin.
PT84899A (en) Process for the preparation of pharmaceutical compositions containing ?-phenyl-1,2-benzisoselenazol-3(2h)-one for the treatment of skin diseases
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO167916C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiolaktam-n-eddiksyrederivater
GB8828694D0 (en) Preparation for introducing active substance for regulating tanning into skin production & use thereof
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
GB8808598D0 (en) Pharmaceutical compositions for treatment of prophylaxis of skin disorders
ZA881828B (en) Preparation for treatment of skin disorders
PL252062A1 (en) Method of obtaining pharmaceutical preparations exibiting prolonged therapeutic action
FI83877B (fi) Foerfarande foer framstaellning av en ny terapeutiskt anvaendbar 7-(3-klorisoxazol-5-yl)-acetamido-3- (1-metyl-1h-1,2,3,4-tetrazol-5-yl)-tiometyl-cef-3-em-4-karboxylsyra
PT85076A (en) Method for the treatment of infections disease by administration of tumor necrosis factor-alpha
GB2173401B (en) Pharmaceutical compositions for the treatment of cerebrovascular and aging brain disorders
ES2007415A6 (es) Procewdimiento de obtencioon de citidina-difosfo-dimetiletanolamina.